Open AccessSodium–glucose cotransporter 2 inhibitors: A drug with antidiabetic and cardioprotective properties
Author(s) -
Li HungYuan
Publication year - 2021
Publication title -
journal of diabetes investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.089
H-Index - 50
eISSN - 2040-1124
pISSN - 2040-1116
DOI - 10.1111/jdi.13413
Subject(s) - medicine , empagliflozin , dapagliflozin , heart failure , diabetes mellitus , ejection fraction , prediabetes , placebo , cardiology , randomized controlled trial , type 2 diabetes , endocrinology , alternative medicine , pathology